Sleep Disturbance And Depression Linked To Worse QoL Among Patients With OAB
- byDoctor News Daily Team
- 05 August, 2025
- 0 Comments
- 0 Mins
 
                            
                                    Overactive bladder (OAB) can have a negative impact on health-related quality of life (HRQoL) and treatment adherence, but the exact nature of their relationship is unclear.
A study published in Neurology and Urodynamics concluded that Among individuals with OAB, Sleep Disturbance, Fatigue, and Depression scores were in line with general population reference values. Based on insights from the subgroup analysis, those taking antidepressants had a lower quality of life (health-related), substantially impacting adherence to their medication, indicating the need for proper assessment and management of depression in this population.
The present study characterized Sleep Disturbance, Depression, Fatigue, and patient-reported medication adherence among adults with overactive bladder in the US.
This study was a descriptive, observational one. Patients completed patient-reported outcome (PRO) measures on their urinary symptoms, anxiety, depression, fatigue, sleep quality, and medication adherence. The researchers then compared these scores across different subgroups based on age, sex, BMI, and medication (sleep and antidepressant) use. They performed exploratory analyses.
Key findings from the study are:
· Of 1013 patients contacted, 159 completed the assessments.
· 67.3% were females. The mean age was ≥65 years of age.
· The most severe OAB symptom was nocturia.
· There were consistent Scale scores for Sleep Disturbance, Fatigue, and Depression with US population norms.
· There were no correlations of moderate or greater magnitude between the severity of lower urinary tract symptoms and Sleep Disturbance, Fatigue, or Depression.
· In comparison to those receiving antidepressants compared to those who were not, outcomes including urinary symptoms, anxiety, and depression were worse.
· Patients taking antidepressants also had poorer adherence to OAB medications.
This noninterventional study assessed sleep disturbance, depression, and other aspects of HRQoL among OAB patients, they said.
Study design, lack of causal relationship, self-reported data, bias and limited generalizability are the study's main limitations.
Study sample including cases of clinically diagnosed with OAB is the major strength of this study.
Reference:
Jensen, S. E et al.An observational, patient‐reported outcome study of sleep quality and depression among individuals with overactive bladder syndrome. Neurourology and Urodynamics. https://doi.org/10.1002/nau.25348
                                
    Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
    The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
    Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
    If you come across any inconsistencies, please reach out to us at 
    admin@doctornewsdaily.com.
    We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
    By using this website, you agree to our 
    Terms of Use, 
    Privacy Policy, and 
    Advertisement Policy.
    For further details, please review our 
    Full Disclaimer.
Recent News
Merck Keytruda wins European Commission nod for lo...
- 30 October, 2025
UP NEET 2025 round 3 allotment results postponed
- 30 October, 2025
Achin Gupta to succeed Umang Vohra as Cipla MD, GC...
- 30 October, 2025
Mumbai shocker: KEM Hospital doctor stabbed by col...
- 30 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
 
                     
                    
0 Comments
Post a comment
No comments yet. Be the first to comment!